Osteoporosis affects about 200 million people world-wide.
According to the International Osteoporosis Foundation (IOF) 1 in 3 women over 50 years will suffer from osteoporosis.
EVAPHARMA has formulated OSTELOS sachets to be taken as granules in oral suspension for the treatment of post-menopausal Osteoporosis.
Active Ingredient : 2 g Strontium Ranelate
Ostelos has a unique dual mode of action by stimulating bone formation and decreasing bone Resorption rebalancing bone turnover in favor of formation.
Ostelos reduces the risk of vertebral , non-vertebral & hip fractures.
The First online medical index in Egypt provided by one of the largest pharmaceutical companies in the Egyptian Market.
FIND A DOCTOR
